Vitamin D

Vitamin D and longevity.

Vitamin D comprises fat-soluble compounds that are essential to human physiology, including cholecalciferol (vitamin D3), produced in the skin after UVB exposure or obtained from animal foods, and ergocalciferol (vitamin D2), found in fungi and irradiated plant products. Both act as prohormones. After absorption, they are hydroxylated in the liver to form 25-hydroxyvitamin D [25(OH)D], then converted mainly in the kidney — and locally in several tissues — to 1,25-dihydroxyvitamin D (calcitriol), the active hormone. Calcitriol binds the vitamin D receptor (VDR) throughout the body and regulates genes involved in mineral metabolism, immunity and cellular function. Most circulating vitamin D is bound to vitamin-D-binding protein (DBP). In clinical practice, both D2 and D3 are used for supplementation, although D3 generally raises 25(OH)D more effectively and for longer. Maintenance intakes commonly range from roughly 400 to 2,000 IU/day, while higher loading regimens may be used for severe deficiency under clinical management.

Aging increases the likelihood of vitamin D deficiency through several mechanisms. Older skin contains less 7-dehydrocholesterol and often receives less sunlight. Hepatic and renal function may also decline, affecting activation of the vitamin, while diet, malabsorption and medications can further reduce vitamin D status. Low 25(OH)D in older adults is associated with poorer bone health, secondary hyperparathyroidism, muscle weakness and greater fall risk. Latitude, season, time of day, clothing, sunscreen and air pollution also affect cutaneous synthesis, which helps explain why deficiency occurs even in sunny climates.

At the cellular level, vitamin D signaling has been linked to several pathways studied in aging. Binding of calcitriol to VDR can modulate antioxidant defenses, including Nrf2-related pathways, and influence genes involved in oxidative stress, mitochondrial function and cellular senescence. Experimental studies also investigate possible relationships with telomere maintenance, epigenetic patterns, SIRT1/PGC-1α signaling and growth-factor regulation. These findings support biological plausibility, but many come from mechanistic or observational work rather than trials showing longer human lifespan.

Protein homeostasis is another area of interest. In Caenorhabditis elegans, vitamin D3 supplementation has been reported to extend lifespan and reduce insoluble protein aggregates through stress-response pathways. Mammalian cell studies suggest that calcitriol can influence chaperone proteins, endoplasmic-reticulum stress responses and autophagy. Direct clinical evidence that vitamin D preserves proteostasis in aging humans remains limited.

Vitamin D also has important immunomodulatory functions. Calcitriol can reduce signaling through inflammatory pathways such as NF-κB, influence cytokines including IL-6 and TNF-α, promote regulatory T-cell responses and support innate defense by inducing antimicrobial peptides such as cathelicidin and defensins. This has led to substantial research on vitamin D in immune aging, chronic low-grade inflammation and respiratory infection risk. Associations, however, do not by themselves establish that supplementation will prevent those outcomes in already replete people.

Observational human studies repeatedly associate low 25(OH)D concentrations with worse age-related outcomes, including higher all-cause mortality, cardiovascular disease, diabetes, osteoporosis, cognitive decline and dementia. Cohort studies such as UK Biobank have reported higher dementia risk among people with severe deficiency. These associations are clinically important but cannot fully separate cause from reverse causation: low vitamin D may partly reflect frailty, less outdoor activity, chronic illness or other health disadvantages.

Experimental models provide stronger evidence that vitamin D signaling is biologically important. Mice lacking VDR develop multiple abnormalities that resemble accelerated aging, including reduced survival, skin and hair changes and neuromuscular impairment. Conversely, some animal studies suggest that correcting vitamin D deficiency can preserve strength or reduce frailty. These results demonstrate the importance of adequate vitamin D biology, but they do not establish that supraphysiologic supplementation extends lifespan.

Randomized human trials are more mixed. A telomere substudy of the large VITAL trial reported a small reduction in leukocyte telomere shortening with 2,000 IU/day of vitamin D3 over several years. Yet large trials have generally not shown major reductions in overall mortality, major cardiovascular events, falls or fractures from vitamin D supplementation in broadly healthy populations without substantial deficiency. Meta-analyses often find small or inconsistent effects, with the clearest rationale for treatment remaining correction of deficiency rather than supplementation far above adequate levels.

Individual response varies. Genetic variants in enzymes such as CYP2R1 and CYP27B1, VDR polymorphisms and DBP variants influence vitamin D metabolism and measured circulating levels. Skin pigmentation, obesity, age, gastrointestinal health, kidney function and medications also affect requirements. Supplementation is therefore not one-size-fits-all and should be interpreted alongside baseline 25(OH)D, body size, diet, comorbidities and other clinical factors.

Vitamin D3 (cholecalciferol) generally has an advantage over vitamin D2 (ergocalciferol) for routine replacement because equivalent D3 doses tend to raise and sustain serum 25(OH)D more effectively. Both can correct deficiency when appropriately dosed. Differences are usually more apparent with intermittent or loading regimens than with modest daily maintenance doses.

Excess vitamin D can be harmful. Because it is fat soluble, chronic very high intake may cause hypercalcemia, leading to nausea, vomiting, constipation, weakness, excessive thirst, kidney stones and calcium deposition in soft tissues. A commonly used serum target range is roughly 20–50 ng/mL (50–125 nmol/L); chronic megadosing should be avoided. Higher-dose regimens warrant monitoring of 25(OH)D and calcium under clinical supervision.

Future research is examining whether correcting deficiency influences biological-age measures, cognition, muscle function and healthy-life expectancy; whether genetic or microbiome markers can identify people most likely to benefit; and whether vitamin D works differently when combined with exercise, omega-3 or other interventions. So far, studies such as VITAL and DO-HEALTH support a nuanced view: vitamin D is essential, deficiency matters, but supplementation in already adequate individuals has not produced dramatic anti-aging effects.

In summary, vitamin D is a multisystem regulator with clear importance for bone, muscle, mineral and immune physiology. Mechanistic and observational research links vitamin D status to several pathways relevant to aging, while randomized trials show that correcting deficiency is more convincing than pursuing high levels for longevity. Maintaining adequate vitamin D through safe sun exposure, diet and/or supplementation can form part of a broader healthy-aging strategy, but it is not a stand-alone anti-aging treatment.